CBER’s Office of Tissues and Advanced Therapies Gets ‘Super Office’ Status, New Name

By PacConAdmin | September 28, 2022

The Center for Biologics Evaluation and Research’s (CBER) Office of Tissues and Advanced Therapies has been renamed the Office of Therapeutic Products (OTP).
Source: Drug Industry Daily

Posted in Drug Industry Daily